Cargando…
Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes
Large numbers of neurological and metabolic disorders occurring in humans are induced by the aberrant growth of aggregated or misfolded proteins. Alzheimer's disease (AD) and type 2 diabetes (T2D) are two of the most prevalent disorders that lead to toxic protofibrils of amyloid beta (Aβ) and h...
Autores principales: | Kumari, Anchala, Somvanshi, Pallavi, Grover, Abhinav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050657/ https://www.ncbi.nlm.nih.gov/pubmed/35497581 http://dx.doi.org/10.1039/d0ra00429d |
Ejemplares similares
-
Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020) -
The polyphenolic phytoalexin polydatin inhibits amyloid aggregation of recombinant human prion protein
por: Sirohi, Preeti Rana, et al.
Publicado: (2021) -
Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)
por: Sharma, Ritika, et al.
Publicado: (2022) -
Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)
por: Sharma, Ritika, et al.
Publicado: (2022) -
Conformational Ensembles of α-Synuclein Derived Peptide with Different Osmolytes from Temperature Replica Exchange Sampling
por: Jamal, Salma, et al.
Publicado: (2017)